AI-HOPE: an AI-driven conversational agent for enhanced clinical and genomic data integration in precision medicine research
Bioinformatics · 2025
DOI: 10.1093/bioinformatics/btaf359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, 2025. Verfasst von Ei-Wen Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: PolyAgent, San Francisco, CA 94102, United States. Hauptthemen laut MEDLINE: Precision Medicine, Genomics, Artificial Intelligence, Computational Biology. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
Motivation The growing complexity of clinical cancer research has fueled a surge in demand for automated bioinformatics tools capable of integrating clinical and genomic data to accelerate discovery efforts. Results We present the Artificial Intelligence Agent for High-Optimization and Precision Medicine (AI-HOPE), an AI-driven system that enables domain experts to conduct integrative data analyses through natural language interactions. Powered by Large Language Models, AI-HOPE interprets user instructions, converts them into executable code, and autonomously analyzes locally stored data. It supports flexible association studies, subset comparisons, clinical prevalence assessments and survival analyses. In addition, AI-HOPE enables global variable scans to identify features significantly associated with a user-defined outcome, making a powerful and intuitive tool for advancing precision medicine research. Importantly, its closed-system design prevents clinical data leakage. To demonstrate its utility, AI-HOPE was applied to The Cancer Genome Atlas data to address two clinical questions. First, it identified significant enrichment of TP53 mutations in late-stage colorectal cancer compared to early-stage cases. Second, it uncovered a strong association between KRAS mutations and poorer progression-free survival in FOLFOX-treated patients. These findings align with established literature and demonstrate AI-HOPE's ability to generate meaningful insights independently, without prior assumptions. By removing programming barriers and simplifying complex analyses, AI-HOPE bridges the gap between data complexity and research needs. With its scalable and adaptable framework, AI-HOPE has the potential to support diverse biomedical research fields, driving innovation and efficiency in translational studies. Availability and implementation The AI-HOPE software and demonstration data is available at https://github.com/Velazquez-Villarreal-Lab/AI-HOPE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- PolyAgent, San Francisco, CA 94102, United States.
- Department of Integrative Translational Sciences, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, United States.
ORCID-Profile: Enrique Velazquez-Villarreal
Förderung
- NCI NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Yang, E. W., & Velazquez-Villarreal, E. (2025). AI-HOPE: an AI-driven conversational agent for enhanced clinical and genomic data integration in precision medicine research. Bioinformatics. https://doi.org/10.1093/bioinformatics/btaf359
Vancouver
Yang EW, Velazquez-Villarreal E. AI-HOPE: an AI-driven conversational agent for enhanced clinical and genomic data integration in precision medicine research. Bioinformatics. 2025. doi:10.1093/bioinformatics/btaf359
BibTeX
@article{Yang2025,
author = {Yang, Ei-Wen and Velazquez-Villarreal, Enrique},
title = {AI-HOPE: an AI-driven conversational agent for enhanced clinical and genomic data integration in precision medicine research},
journal = {Bioinformatics},
year = {2025},
doi = {10.1093/bioinformatics/btaf359}
}
EUVIMED